CLINICAL GENOMICS
Genetic Risk Assessment
Empowering clinical teams through time-saving, automated insights
Automate relevant patient and family history to quickly identify patients who may meet guideline-based criteria for hereditary cancer or cardiovascular genetic testing and obtain prospective consent. This efficiency allows you to shift your focus from administration to high-value clinical management. The Helix Genetic Risk Assessment enables providers to systematically identify individuals who meet clinical criteria for genetic testing and initiate care pathways that prioritize answers over paperwork.
Redefining the standard of care
A guideline-driven genetic testing workflow that saves you time:
1. Patient completes assessment and potential eligibility flagged for provider review
2. Patient is educated and prospective informed consent is collected electronically
3. A test order is automatically generated and flagged in the provider's queue for eligible patients
4. Provider can review and order in just a few clicks, saving significant clinical time
Closing the gap between patient history and clinical action
Relevant personal and family history can sometimes be difficult to surface within standard patient records, creating potential gaps in proactive care delivery. Our genetic risk assessment utilizes rules-based logic to systematically surface these individuals across cancer and cardiovascular care pathways through digital patient intake, aligning patient data with national clinical guidelines, and ensuring that patients who meet the criteria are identified and their providers are equipped to initiate proactive, evidence-based care.
A more human experience through digital efficiency
We believe precision health should be accessible to everyone. By prioritizing a streamlined and intuitive design, we’ve created an assessment experience focused on ease of use. This intuitive, user-friendly platform is designed for efficiency and engagement, ensuring a simple and supportive experience within a seamless, accessible workflow.
Empowering your clinical team to lead
Evidence-based confidence
Provide specialists with the clear, guideline-backed justification they need to authorize testing at the point of care.
A seamless path to consent
Streamline administrative tasks by automating the delivery of education and obtaining digital informed consent, ensuring patients are prepared if their provider determines testing is appropriate.
Reclaiming professional expertise
Free your genetic counselors to focus on complex cases and high-value care coordination while the assessment handles routine intake and education.
Ready to scale your precision health program?
Discover how streamlining identification of patients meeting clinical guidelines for genetic testing can help your team work at the top of their license and improve patient outcomes. Request a personalized demo to see our genetic risk assessment in action and explore the future of automated clinical genomics.
The Helix Genetic Risk Assessment evaluates whether a patient meets published, guideline-based criteria for genetic testing based on patient-reported personal and family health history, applying criteria consistent with criteria from the American Heart Association, Heart Rhythm Society, the American College of Cardiology, NCCN®, ASCO, Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) and other leading professional organizations. Helix is not affiliated with, endorsed by, or sponsored by the American Heart Association, Heart Rhythm Society, the American College of Cardiology, NCCN®, ASCO, or the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC). The trademarks referring to these entities are owned by their respective organizations. All references to such trademarks are for identification purposes only and do not imply any association, sponsorship, or endorsement. . The assessment is not a diagnosis. Providers should independently review results and exercise clinical judgment before approving any test order. This assessment does not evaluate or guarantee eligibility for insurance coverage, reimbursement, or payment for genetic testing.